therapeutic radiopharmaceuticals	belong to	ATC
ATC	classifies	therapeutic radiopharmaceuticals
therapeutic radiopharmaceuticals	used for	cancer treatment
cancer treatment	requires	radiotherapy
radiotherapy	employs	therapeutic radiopharmaceuticals
therapeutic radiopharmaceuticals	deliver	targeted radiation
targeted radiation	kills	tumor cells
tumor cells	express	specific receptors
specific receptors	bind to	radiopharmaceuticals
radiopharmaceuticals	contain	radioactive isotopes
radioactive isotopes	emit	beta particles
beta particles	damage	DNA
DNA damage	induces	apoptosis
apoptosis	reduces	tumor burden
tumor burden	correlates with	survival
survival	predicts	prognosis
prognosis	informs	treatment plan
treatment plan	includes	dose calculation
dose calculation	uses	dosimetry
dosimetry	measures	absorbed dose
absorbed dose	predicts	toxicity
toxicity	affects	quality of life
quality of life	influences	readmission risk
readmission risk	predicts	healthcare cost
healthcare cost	informs	resource allocation
resource allocation	optimizes	hospital throughput
hospital throughput	improves	patient flow
patient flow	reduces	waiting time
waiting time	lowers	patient anxiety
patient anxiety	decreases	medication non‑adherence
medication non‑adherence	increases	relapse risk
relapse risk	necessitates	salvage therapy
salvage therapy	may use	alternative radiopharmaceuticals
alternative radiopharmaceuticals	differ in	half‑life
half‑life	determines	logistical planning
logistical planning	affects	inventory management
inventory management	impacts	drug availability
drug availability	influences	treatment initiation
treatment initiation	correlates with	early response
early response	predicts	long‑term survival
long‑term survival	used in	clinical trials
clinical trials	report	efficacy data
efficacy data	guide	regulatory approval
regulatory approval	sets	reimbursement policy
reimbursement policy	determines	patient access
patient access	affects	adherence rates
adherence rates	influence	outcome variability
outcome variability	drives	personalized medicine
personalized medicine	relies on	biomarker profiling
biomarker profiling	identifies	targetable receptors
targetable receptors	select	specific radiopharmaceuticals
specific radiopharmaceuticals	have	affinity
affinity	affects	tumor uptake
tumor uptake	measured by	PET imaging
PET imaging	quantifies	standardized uptake value
standardized uptake value	predicts	therapeutic response
therapeutic response	informs	dose escalation
dose escalation	balances	efficacy and toxicity
efficacy	measured by	progression‑free survival
progression‑free survival	correlates with	overall survival
overall survival	used in	health‑economic models
health‑economic models	estimate	cost‑effectiveness
cost‑effectiveness	guides	payer decisions
payer decisions	influence	formulary status
formulary status	determines	prescribing patterns
prescribing patterns	affect	drug utilization
drug utilization	monitored by	pharmacy data
pharmacy data	reveal	adherence trends
adherence trends	predict	hospitalization rates
hospitalization rates	impact	readmission risk
readmission risk	used in	risk stratification
risk stratification	informs	discharge planning
discharge planning	includes	home‑care services
home‑care services	reduce	complications
complications	lower	mortality
mortality	is a key	outcome metric
outcome metric	feeds back	quality improvement
quality improvement	updates	clinical guidelines
clinical guidelines	recommend	specific radiopharmaceuticals
specific radiopharmaceuticals	are	technetium‑99m agents
technetium‑99m agents	are	short‑half‑life
short‑half‑life	enables	outpatient therapy
outpatient therapy	improves	patient convenience
patient convenience	boosts	adherence
adherence	reduces	treatment failure
treatment failure	increases	secondary interventions
secondary interventions	may involve	surgery
surgery	requires	pre‑operative imaging
pre‑operative imaging	uses	radiopharmaceuticals
radiopharmaceuticals	are	diagnostic agents
diagnostic agents	guide	therapeutic decisions
therapeutic decisions	impact	survival
survival	is influenced by	comorbidities
comorbidities	affect	treatment tolerance
treatment tolerance	determines	dose limits
dose limits	set	safety thresholds
safety thresholds	derived from	toxicity studies
toxicity studies	report	adverse events
adverse events	predict	monitoring frequency
monitoring frequency	reduces	emergency visits
